Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants

Biochemical Pharmacology

Volumn 63, Issue 3, 2002, Pages 533-541

  Chen, Xin ^a   Mellon, Richard Daniel ^a   Yang, Lu ^a   Dong, Huifang ^b   Oppenheim, Joost J ^a   Howard, Ola Mae Zack ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Calcium mobilization; Chemokine chemotaattractant; Chemotaxis; Deoxycholic acid (DCA); Human leukocyte; Ligand receptor binding

Indexed keywords

ALPHA CHEMOKINE; ANTIINFLAMMATORY AGENT; BETA CHEMOKINE; CHEMOATTRACTANT; COMPLEMENT COMPONENT C5A; DEOXYCHOLIC ACID; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; NIUHUANG; RECEPTOR ANTIBODY; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CELL FUNCTION; CELL SUSPENSION; CELL TRANSPORT; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; STEREOSPECIFICITY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES; CALCIUM; CELL MOVEMENT; CELL RESPIRATION; CHEMOKINES; CHEMOTACTIC FACTORS; DEOXYCHOLIC ACID; DRUG INTERACTIONS; HUMANS; INTERLEUKIN-8; LEUKOCYTES; MEDICINE, CHINESE TRADITIONAL; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RECEPTORS, PEPTIDE; TRITIUM;

EID: 0036472061     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00917-0     Document Type: Article

References (48)

1. Research on Calculus bovis
2. Pharmacological study of a traditional Chinese medicine: Effect of Bezoar bovis on the irregular beating pattern of cultured mouse myocardial cells
3. Effectiveness of bovine gallstone (Goou) and bear gall powder (Yutan) on chronic liver diseases: A preliminary report
4. Pharmacological action of cultured Calculus bovis
5. Ethnopharmacology of bear gall bladder: I
6. Effect of Calculus bovis on immune functions in mice
7. TLC-colorimetric assay of cholic acid in bezoars and angong niuhuang pills
8. Fundamental studies on the evaluation of crude drug. VII. On animal gall (1)
9. Identification and differentiation of bear bile used in medicinal products in Taiwan
10. Application of colorimetric-equal value derivative spectrometry to the determination of cholic acid in niuhuang jiedu pian (tablet)
11. Nuclear receptor regulation of cholesterol and bile acid metabolism
12. The molecular biology of leukocyte chemoattractant receptors
13. Are chemokines essential or secondary participants in allergic responses?
14. Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors
15. Fundamental research for the pharmacological activity of oriental drugs. XI. Combined effects of animal-origin drugs on the inhibition of leucocyte migration and their effective components (author's translation)
16. Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS
17. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
18. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
19. N-Formylmethionyl peptides as chemoattractants for leucocytes
20. C5a anaphylatoxin and its seven transmembrane-segment receptor
21. 4 to receptors on human polymorphonuclear leukocytes
22. Platelet activating factor: A biologically active phosphoglyceride
23. Human chemokines: An update
24. Chemokine receptors - Future therapeutic targets for HIV?
25. Chemokines and their role in tumor growth and metastasis
26. Chemokine receptors and their role in inflammation and infectious diseases
27. Chemokines as molecular targets for therapeutic intervention
28. International union of pharmacology. XXII. Nomenclature for chemokine receptors
29. Interfering with chemokine networks - The hope for new therapeutics
30. The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
31. Cellular responses to FMLP challenging: A mini-review
32. Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease
33. Acute colitis produced by chemotactic peptides in rats and mice
34. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: The role of phosphatidylinositol 3-kinase
35. - generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils
36. 3H]FMLP binding
37. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors
38. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils
39. Ryanodine as inhibitor of chemotactic peptide-induced chemotaxis in human neutrophils
40. Physicochemical properties of bile acids and their relationship to biological properties: An overview of the problem
41. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: An in vitro study
42. Degradation of steroids in the human gut
43. Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation
44. Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects
45. Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon
46. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids
47. Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria
48. Radio-immunoassay for formyl methionyl leucyl phenylalanine. II. Demonstration of an enterohepatic circulation of immunoreactive bacterial chemotactic peptides in man